Barcos M - Search Results

1

Prediction of response of acute nonlymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.

Preisler HD, Epstein J, Barcos M, Priore R, Raza A, Browman GP, Vogler R, Winton E, Grunwald H, Rai K, et al. Preisler HD, et al. Among authors: barcos m. Br J Haematol. 1984 Sep;58(1):19-32. doi: 10.1111/j.1365-2141.1984.tb06055.x. Br J Haematol. 1984. PMID: 6466567

2

Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements.

Preisler HD, Priore R, Azarnia N, Barcos M, Raza A, Rakowski I, Vogler R, Winton EL, Browman G, Goldberg J, et al. Preisler HD, et al. Among authors: barcos m. Br J Haematol. 1986 Aug;63(4):625-36. doi: 10.1111/j.1365-2141.1986.tb07546.x. Br J Haematol. 1986. PMID: 3460626

3

High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study.

Preisler HD, Raza A, Barcos M, Azarnia N, Larson R, Browman G, Walker I, Grunwald H, D'Arrigo P, Stein A, et al. Preisler HD, et al. Among authors: barcos m. Am J Hematol. 1986 Oct;23(2):131-4. doi: 10.1002/ajh.2830230207. Am J Hematol. 1986. PMID: 3529939 Clinical Trial.

4

High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.

Preisler HD, Raza A, Barcos M, Azarnia N, Larson R, Walker I, Browman M, Grunwald H, D'Arrigo P, Doeblin T, et al. Preisler HD, et al. Among authors: barcos m. J Clin Oncol. 1987 Jan;5(1):75-82. doi: 10.1200/JCO.1987.5.1.75. J Clin Oncol. 1987. PMID: 3806162

5

Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: relationship to response to remission induction therapy.

Preisler HD, Raza A, Azarnia N, Rakowsky I, Barcos M, Browman G, Booker L, Goldberg J, Gottleib A, Brennan J, et al. Preisler HD, et al. Among authors: barcos m. Eur J Cancer Clin Oncol. 1985 May;21(5):563-71. doi: 10.1016/0277-5379(85)90081-1. Eur J Cancer Clin Oncol. 1985. PMID: 3859416

6

Treatment of dysmyelopoietic/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinoside.

Preisler HD, Raza A, Barcos M. Preisler HD, et al. Among authors: barcos m. Med Oncol Tumor Pharmacother. 1985;2(2):87-91. doi: 10.1007/BF02934853. Med Oncol Tumor Pharmacother. 1985. PMID: 4058079

7

Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup study.

Raza A, Preisler HD, Day R, Yasin Z, White M, Lykins J, Kukla C, Barcos M, Bennett J, Browman G, et al. Raza A, et al. Among authors: barcos m. Blood. 1990 Dec 1;76(11):2191-7. Blood. 1990. PMID: 2257293 Free article.

8

Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: utility of day 6 bone marrow biopsy.

Preisler H, Barcos M, Reese P, Priore RL, Pothier L. Preisler H, et al. Among authors: barcos m. Leuk Res. 1983;7(1):67-75. doi: 10.1016/0145-2126(83)90059-0. Leuk Res. 1983. PMID: 6572773

9

Ph1-positive acute leukemia.

Raza A, Minowada J, Barcos M, Rakowski I, Preisler HD. Raza A, et al. Among authors: barcos m. Eur J Cancer Clin Oncol. 1984 Dec;20(12):1509-16. doi: 10.1016/0277-5379(84)90144-5. Eur J Cancer Clin Oncol. 1984. PMID: 6594242

10

Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986.

Baer MR, Barcos M, Farrell H, Raza A, Preisler HD. Baer MR, et al. Among authors: barcos m. Cancer. 1989 Jun 1;63(11):2192-200. doi: 10.1002/1097-0142(19890601)63:11<2192::aid-cncr2820631122>3.0.co;2-r. Cancer. 1989. PMID: 2785843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters